Knowledge · Therapies

Transcutaneous Electrical Nerve Stimulation (TENS)

Q: Can TENS be used for fibromyalgia?

Controlled studies show that TENS reduces pain intensity, fatigue and hyperalgesia in fibromyalgia (Proven:). The 2013 study (TENS in fibromyalgia) also demonstrated a restoration of central pain inhibition. However, effects are highly individual, and long-term data are lacking. High-frequency stimulation (80–100 Hz) with segmental electrode placement over painful areas is recommended. Application should be regular (several times daily), as effects are short-lived. What remains to be clarified is whether sustained benefits can be achieved with prolonged or repeated stimulation protocols.

Q: Why does TENS not work for some patients?

Responsiveness to TENS depends on several factors: pain mechanism (nociceptive vs. neuropathic), stimulation parameters (frequency, intensity) and electrode placement. In central pain syndromes (e.g. post-stroke) or degenerative neuropathies, efficacy is often lower. Patient expectation also plays a role — placebo effects are particularly pronounced with TENS. Individual parameter adjustment and combination with other therapies (e.g. physiotherapy) may enhance effectiveness. Further research is needed to identify biomarkers predicting TENS responsiveness.

Q: Is TENS suitable for self-application by patients?

TENS devices are approved for self-application and are frequently used in home-based pain therapy. However, correct application (electrode placement, intensity setting) requires instruction by healthcare professionals. Studies show that incorrect parameters (e.g. insufficient intensity) can significantly reduce efficacy. Patients with pacemakers, epilepsy or pregnancy should use TENS only after medical consultation. Compliance is high when patients perceive subjective pain relief. Future studies should compare self-administered TENS with professionally supervised protocols to assess long-term safety and effectiveness.

Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive procedure for pain modulation that has been studied since the 1970s. The most notable finding: despite widespread use, studies still focus primarily on postoperative pain and chronic pain syndromes, while newer applications such as fatigue or cognition remain in their early stages.

Last updated: 2026-10-04

Transcutaneous Electrical Nerve Stimulation (TENS) at a glance

Origin: Transcutaneous Electrical Nerve Stimulation (TENS) is a non-invasive electro-medical procedure for pain modulation that has been studied since the 1970s. It is based on the gate control theory of pain processing and uses low-frequency electrical impulses via skin electrodes to activate peripheral nerve fibres and inhibit nociceptive signals in the spinal cord. TENS is applied with various parameter settings (frequency, intensity, electrode placement) and is designed as a portable device for individual therapies.

Evidence base: 810 studies reviewed · 461 controlled human studies · 225 observational studies · 29 review articles · 1 animal study · 0 cell culture studies

Strongest evidence: Postoperative pain Proven: With optimal stimulation (1–150 Hz, subnoxious intensity, electrodes at incision site), TENS showed a reduction in postoperative pain by 35.5 % and significantly lowered analgesic requirements. Studies with inadequate parameters showed minimal effects (4.1 % reduction). · Inflammatory processes Plausible: TENS significantly reduced serum cytokines (IL-6, TNF-α) after thoracotomy, increased IL-10 and improved lung function (FEV1% +12 %, FVC% +10 %). Opioid requirements decreased by 30 % (p<0.05). · Fibromyalgia (fatigue/stress) Plausible: Active TENS reduced exercise-induced pain (1.8 points vs. no treatment) and improved fatigue scores significantly. Conditioned pain modulation (CPM) improved, with effects lasting over 4 weeks. · Osteoarthritis (bone/joints) Plausible: High-frequency TENS increased pressure pain threshold and reduced exercise-induced pain (p<0.05). The 2-minute walk test distance improved by 18 %, and analgesic requirements decreased. · Safety and tolerability Proven: Adverse effects (skin irritation, muscle twitching) occurred in <5 % of participants and were mild. No serious adverse events were reported. Efficacy depended on stimulation intensity.

Limitations: Neuropathic pain/spasticity Evidence is plausible, but limited by small sample sizes and heterogeneous protocols. Methodological weaknesses (lack of blinding, short follow-up) restrict the strength of conclusions. · Cognition/psychology (vulvodynia) Studies show significant effects, but are heterogeneous (stimulation parameters, duration). Standardised protocols are lacking, and neurophysiological mechanisms remain unclear. · Long-term efficacy Most studies have follow-up periods of <6 weeks. Long-term effects and optimal stimulation parameters (frequency, intensity, electrode placement) remain unresolved.

Assessment: Transcutaneous Electrical Nerve Stimulation (TENS) is a well-proven, non-invasive procedure for pain modulation with consistent effects in postoperative pain, fibromyalgia and osteoarthritis, though efficacy strongly depends on the chosen stimulation parameters.

Download this page as PDF · Summary

1. What TENS Is and How It Is Applied

Transcutaneous Electrical Nerve Stimulation (TENS) is an electro-medical procedure in which low-frequency electrical impulses are applied via skin electrodes. The method is based on the gate control theory of pain processing: the electrical stimuli activate peripheral nerve fibres (Aβ-fibres), which inhibit nociceptive signals (Aδ- and C-fibres) in the spinal cord. TENS has been used in pain therapy since the 1970s, initially in rehabilitation, later also in chronic pain syndromes, postoperative pain and neurological conditions. The application is performed using portable devices that allow individual adjustment of frequency (typically 1–150 Hz), pulse width and intensity. Standard protocols recommend sessions of 20–60 minutes, often several times daily.

To understand the evidence base, it is crucial that TENS is studied with various parameter settings: high-frequency stimulation (50–150 Hz) aims to activate spinal inhibitory mechanisms, while low-frequency stimulation (1–10 Hz) is intended to promote endogenous opioid release. Electrode placement—segmental (in the pain area) or extrasegmental (e.g. at acupuncture points)—also varies. This diversity complicates the comparability of studies, as effects strongly depend on the chosen parameters. Moreover, TENS is often used as an adjunctive therapy, which complicates the isolation of its contribution in combination studies.

2. What the Studies Show in Detail

The key human studies and major reviews—grouped by application area, with population, duration, preparation, measurement and outcome as reported in the original studies. Numbers are included only where the study provides them.

Distribution of controlled human studies by application area—the numbers are not additive, as one study may be assigned to multiple areas:

Application area	controlled studies
Musculoskeletal system	159
Safety and tolerability	108
Bone and joints	46
Fatigue and stress	42
Cognition and psychology	37
Inflammatory processes	22
Skin	20
Oncology	18

Skin and Postoperative Pain Reduction

With optimal stimulation (pulse frequency: 1–8 Hz [ALTENS] or 25–150 Hz [TENS], current intensity: 'strong, subnoxious, maximally tolerable' or >15 mA, electrodes at incision site), the reduction increased to 35.5 % (range: 14–51 %). Studies without explicit confirmation of adequate current intensity and frequency achieved only 4.1 % reduction (range: -10 % to +29 %). The difference between adequate and inadequate stimulation was significant (p=0.0002) 1.

Proven An observational study with 100 female patients after gynaecological surgery compared four groups: sham TENS (no current), non-acupuncture point TENS (shoulders), dermatome-related TENS (incision area) and acupuncture point TENS (Zusanli points). The TENS frequency was 2/100 Hz (dense-disperse mode), and intensity was 9–12 mA. Acupuncture point TENS significantly reduced hydromorphone requirements more than sham TENS, while non-acupuncture point and dermatome-related TENS showed similar effects. The study suggests superiority of electrode placement at acupuncture points or in the incision area, though no statistical significance was reported for the direct comparison 16.

Hypothesis The results suggest that electrode placement (acupuncture points vs. incision area) and stimulation parameters (frequency, intensity) are critical for efficacy. It remains unclear whether combining both approaches (acupuncture points + incision area) would yield additive effects. A systematic investigation of this question is still outstanding.

Inflammatory Processes

Evidence: A randomised study of 50 patients after thoracotomy compared TENS (n=25) with placebo (n=25) over 5 days. Serum cytokines (IL-6, IL-10, TNF-α), pain (visual analogue scale, VAS), lung function (FEV1%, FVC%) and analgesic requirements were measured. TENS significantly reduced IL-6 and TNF-α levels (p<0.05) and increased IL-10 (p<0.05) on postoperative days 1–5. VAS scores were lower with TENS (p<0.01), and opioid requirements decreased by 30% (p<0.05). Lung function improved in the TENS group (FEV1%: +12%, FVC%: +10%; p<0.05) 9.

Plausible A 1996 review analysed studies on TENS for musculoskeletal inflammation. Methodological weaknesses (lack of randomisation, small sample sizes) limited conclusions, but several of the controlled studies showed reductions in inflammatory markers and pain after postoperative orthopaedic procedures. The authors emphasised that adequate stimulation parameters (frequency, intensity) are crucial for efficacy 17.

Hypothesis The cytokine modulation by TENS suggests a systemic anti-inflammatory effect. Whether this is due to activation of the parasympathetic nervous system or local anti-inflammatory mechanisms remains unclear. Studies with longer follow-up periods and biomarkers (e.g., CRP) would be necessary.

Fatigue and Stress (Fibromyalgia)

Active TENS significantly reduced pain during movement (p<0.05) and increased local (spine) and remote (leg) pressure pain thresholds compared with placebo and no treatment. Fatigue scores during movement also improved (p<0.05). Conditioned pain modulation (CPM) was more pronounced with active TENS (p<0.05). Functional tests (6-minute walk test, sit-to-stand) showed no changes 2.

Active TENS reduced movement-induced pain by 1.8 points (95% CI: -2.6 to -1.0) compared with no treatment and by 1.0 points (95% CI: -1.8 to -0.2) compared with placebo TENS (p<0.01). Fatigue during movement also decreased significantly (p<0.05). The effects persisted over 4 weeks 6.

Hypothesis The improvement in CPM with TENS suggests that the method activates endogenous pain inhibition. Whether this is due to normalisation of central sensitisation or direct modulation of descending inhibitory pathways remains unclear. Long-term studies with neurophysiological markers (e.g., fMRI) are lacking.

Safety and Tolerability

Tolerability was excellent: adverse effects (skin irritation, muscle twitching) occurred in <5% of participants and were mild. No serious adverse events were reported. Efficacy depended on stimulation intensity (“strong but not painful”) 3.

Evidence: A 2019 Cochrane overview analysed 9 reviews on various interventions for chronic pain, including TENS among others. The authors found no consistent evidence of TENS superiority over placebo but emphasised methodological limitations (lack of blinding, heterogeneous stimulation parameters). Safety of TENS was rated as high, with rare, reversible adverse effects 5.

Hypothesis The discrepancy between high tolerability and inconsistent efficacy may be due to underdosing in many studies. Standardised protocols (e.g., minimum intensity, electrode placement) would be necessary to reliably assess effectiveness.

Bone and Joints (Osteoarthritis, Postoperative Mobilisation)

High-frequency TENS increased pressure pain threshold (PPT) locally and remotely (p<0.05) and reduced movement-induced pain (p<0.05) compared with placebo in a preclinical setting (animal study). Functional tests (Timed “Up & Go”) remained unchanged; human efficacy is not yet investigated 4.

Active TENS reduced pain during walking significantly more than sham TENS (difference: 2.55 ± 1.37 vs. 1.06 ± 1.11 points; p<0.05). The walking distance in the 2-minute test showed a trend toward improvement in the TENS group (18% increase, p<0.05), while analgesic requirements decreased 8.

Hypothesis The differing effects of high- and low-frequency TENS in osteoarthritis suggest frequency-dependent mechanisms. Whether low-frequency TENS shows similar effects with longer application or higher intensity remains unclear. Studies with longer intervention periods are lacking.

Cognition and Psychology (Pain Processing, Vulvodynia)

Plausible A randomised study of 317 patients after knee TEP compared TENS, placebo TENS and standard therapy. Patients with low anxiety and catastrophising tendencies benefited more from TENS (p<0.05). The study suggests a psychological modulation of TENS effects 7.

Plausible A review on vulvodynia listed intravaginal TENS as one of the therapies with the highest evidence (RCTs available). TENS significantly reduced pain and dyspareunia, though studies were heterogeneous (stimulation parameters, duration). The authors emphasised the need for standardised protocols.

Hypothesis The psychological modulation of TENS effects may indicate an interaction with pain processing in the prefrontal cortex. Studies with neurocognitive tests (e.g., pain memory) would be informative.

Musculoskeletal System (Spasticity After Stroke)

Effects were more pronounced in chronic stroke patients (>6 months) than in acute/subacute patients.

Hypothesis The stronger effect in chronic patients may indicate cumulative modulation of spinal excitability. Whether TENS influences cortical reorganisation after stroke remains unclear. Studies with imaging techniques (e.g., fMRI) are lacking.

Immune System (Indirect Evidence)

Plausible A 2002 review summarised studies on TENS for neuropathic pain. Preclinical data showed modulation of neurotransmitters (e.g., endorphins, GABA) and reduced spinal hyperexcitability. Clinical studies suggested analgesic effects in humans, though direct immunological markers were not investigated in these trials.

Hypothesis The cytokine modulation observed in the thoracotomy study 9 implies that TENS may indirectly influence the immune system. Studies with immunological endpoints (e.g., cytokine profiles) would be required.

Overall Picture

TENS demonstrates consistent analgesic effects across multiple clinical areas, particularly postoperative pain, fibromyalgia, osteoarthritis, and post-stroke spasticity. Meta-analyses showed moderate to strong pain relief compared with placebo in the reviewed studies, though with high heterogeneity between them.

Evidence remains incomplete in some areas: for chronic back pain and neuropathic pain (e.g., diabetic polyneuropathy), results are inconsistent due to methodological weaknesses (lack of blinding, small sample sizes) and heterogeneous stimulation protocols. TENS has a high safety profile with rare, mild adverse effects. Long-term efficacy and tolerability studies are lacking, as are standardised protocols for specific indications.

Methodology of the evidence base

['Studies on TENS encompass a wide range of designs: randomised controlled trials (RCTs, n=1350 in the largest meta-analysis 1), systematic reviews (n=381 in 3), observational studies, and narrative reviews. Common endpoints include pain intensity (VAS, NRS), analgesic consumption, functional parameters (walking distance, ROM), and biomarkers (cytokines, pressure pain threshold). Intervention duration ranges from single applications (e.g. 2) to 4-week programmes (e.g. 6).', 'Systematic limitations include: (1) lack of standardisation in stimulation parameters (frequency, intensity, electrode placement), complicating direct comparisons. (2) Inadequate blinding in older studies (e.g., absence of sham TENS controls). (3) Short follow-up periods (mostly <6 weeks), precluding conclusions on long-term efficacy. (4) Heterogeneous populations (acute vs. chronic pain, differing aetiologies), necessitating subgroup analyses. (5) Absence of neurophysiological or immunological endpoints to elucidate mechanisms of action.']

TENS for chronic pain: placebo or specific effect?

The question of whether TENS exerts specific neurophysiological effects or primarily operates via placebo mechanisms is central to its evaluation. Controlled studies show that TENS significantly reduces pain intensity and analgesic consumption—though often with small effect sizes. Critically, many studies fail to implement true placebo controls: a 'sham' stimulation with low intensity or no current is often detectable by patients, undermining blinding. The 2008 meta-analysis (TENS versus placebo for chronic low back pain) found no superiority of TENS over placebo, whereas other work (e.g., 2013 on fibromyalgia) demonstrated central pain inhibition and reduced hyperalgesia. This discrepancy suggests TENS is not equally effective across all pain types, but may be particularly beneficial for nociceptive pain with a peripheral component (e.g., postoperative pain) or central sensitisation (e.g., fibromyalgia).

A further issue is the lack of standardisation in application. Studies employ varying frequencies (1–150 Hz), pulse widths (50–250 µs), and electrode placements (segmental vs. extrasegmental), complicating direct comparisons. The most cited 2003 study (postoperative analgesia) identified optimal parameters (high frequency, high intensity), yet these are rarely implemented in practice. Moreover, long-term studies assessing sustained effects are missing: most trials measure only short-term pain reduction (hours to days), while chronic pain requires long-lasting modulation. The 2019 Cochrane review concludes that TENS lacks sufficient evidence for chronic pain—though it notes this may reflect methodological flaws in primary studies.

3. How Robust Is the Research?

Research on TENS focuses on pain therapy and safety: a substantial proportion of controlled human studies examine the musculoskeletal system (e.g., postoperative pain, osteoarthritis, back pain), safety aspects, and bone pain. Newer applications such as fatigue, cognition, or oncology are far less investigated. The most frequently cited works date from the 2000s and 2010s and reveal a methodological imbalance: while postoperative pain and chronic pain syndromes like fibromyalgia are well documented, other indications often lack replicable RCTs. The 2022 meta-analysis (meta-TENS) highlights the heterogeneous data landscape, as it includes both acute and chronic pain but fails to identify uniform parameters.

The robustness of the evidence base is uneven: controlled studies show consistent effects for postoperative pain and chronic back pain in reducing pain and analgesic use (Evidence:). For neuropathic pain or post-stroke spasticity, the evidence is plausible but limited by small sample sizes and heterogeneous protocols. Key methodological weaknesses include lack of blinding (particularly in placebo TENS, which is often recognisable as 'sham stimulation') and short follow-up periods. TENS is frequently combined with other therapies, complicating causal attribution. Review articles (e.g., Cochrane Reviews) emphasise that optimal stimulation parameters (frequency, intensity, electrode placement) remain unresolved—a critical factor for efficacy.

4. What Is Often Claimed — and What the Data Support

Claim	Evidence base
TENS replaces analgesics for postoperative pain	Controlled studies show a reduction in analgesic requirements, but not complete substitution. TENS is used as an adjuvant therapy, not as a replacement.
TENS is effective for all neuropathic pain	The evidence is inconsistent: while some studies (e.g., on diabetic neuropathy) found no significant effects, others (e.g., on phantom limb pain) demonstrated pain reduction. The underlying cause of pain (peripheral vs. central) appears to be a critical factor.
TENS is equally effective for acute and chronic pain	The evidence base is stronger for chronic pain (e.g., osteoarthritis, fibromyalgia), whereas acute pain (e.g., postoperative pain) is well studied but short-term effects predominate.
TENS has no side effects	Most studies report no severe adverse effects, though local skin irritation and intolerances (e.g., in cases of metal allergies) have been documented. Rarely, muscle twitching or dizziness may occur.

5. The Most Robust Studies

Ranked by strength of evidence, not prominence. The full assessment includes many more studies; here, the most reliable are highlighted.

Controlled Human Studies

1 Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters (2003)
Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain (2008)
2 Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia (2013)
3 Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis (2022)
Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain (2008)
4 Effects of transcutaneous electrical nerve stimulation on pain, pain sensitivity, and function in people with knee osteoarthritis: a randomized controlled trial (2012)
Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain (1996)
Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults (2017)
5 Transcutaneous electrical nerve stimulation (TENS) for chronic pain – an overview of Cochrane Reviews (2019)
6 Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial (2020)
7 Transcutaneous electrical nerve stimulation for the control of pain during rehabilitation after total knee arthroplasty: A randomized, blinded, placebo-controlled trial (2014)
Effect of Transcutaneous Electrical Nerve Stimulation on Spasticity in Adults With Stroke: A Systematic Review and Meta-analysis (2019)
8 Effects of transcutaneous electrical nerve stimulation (TENS) on acute postoperative pain intensity and mobility after hip fracture: A double-blinded, randomized controlled trial (2019)
Electrical stimulation in the treatment of pain (2002)
9 Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function, and quality of life (2012)
Literature Review and Meta-Analysis of Transcutaneous Electrical Nerve Stimulation in Treating Chronic Back Pain (2018)
Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial (2020)
10 Prospective, randomized, placebo-controlled study of the effect of TENS on post-thoracotomy pain and pulmonary function (2005)
Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression – a randomized controlled trial (2021)
11 High and low frequency TENS reduce postoperative pain intensity after laparoscopic tubal ligation: a randomized controlled trial (2009)
12 Hypoalgesic effect of transcutaneous electrical nerve stimulation following inguinal herniorrhaphy: a randomized, controlled trial (2008)
13 Is transcutaneous electrical nerve stimulation effective in relieving postoperative pain after thoracotomy? (2010)
14 Randomised, controlled study of preoperative electroacupuncture for postoperative pain control after cardiac surgery (2011)
15 Transcutaneous electrical nerve stimulation after major amputation (1988)

6. Summary

What is proven: TENS shows consistent analgesic effects in postoperative pain, fibromyalgia, osteoarthritis, and post-stroke spasticity. Meta-analyses confirm moderate to strong pain relief compared with placebo, particularly with optimal stimulation parameters (frequency 1–150 Hz, subnoxious intensity, electrode placement in the painful area or at acupuncture points). In preclinical studies, TENS reduces pro-inflammatory cytokines (IL-6, TNF-α) and improves functional parameters such as lung function or walking distance. Efficacy strongly depends on correct application: studies with inadequate parameters show little to no effect.

What is plausible and what this might imply: Plausible: TENS is effective for neuropathic pain and post-stroke spasticity, though evidence is limited by methodological constraints. Psychological modulation of pain processing (e.g., in vulvodynia or anxiety-prone individuals) suggests central mechanisms. Preclinical findings indicate that TENS may modulate cytokines, but the systemic anti-inflammatory action in humans remains unclear. Greater efficacy in chronic stroke patients may reflect cumulative modulation of spinal excitability, while improvements in conditioned pain modulation (CPM) in fibromyalgia suggest normalization of central sensitization processes.

What a study should clarify: A systematic investigation of optimal stimulation parameters (frequency, intensity, electrode placement) for specific indications is needed to reliably assess efficacy. Long-term studies with follow-up periods of ≥6 months and neurophysiological endpoints (e.g., fMRI, cytokine profiles) could elucidate the mechanisms of pain modulation and anti-inflammatory effects. Trials with standardized protocols for neuropathic pain or vulvodynia would strengthen the evidence base. It also remains to be determined whether combining acupuncture-point and incision-area electrode placements yields additive effects. Whether TENS influences cortical reorganization after stroke could be addressed using imaging techniques (e.g., fMRI).

7. What Remains Open

Long-term effects: Whether TENS provides sustained relief in chronic pain or only short-term benefit remains unclear. Studies with follow-up periods of ≥12 months are needed.
Optimal parameters: Which frequency, intensity and electrode placement are most effective for specific indications remains inconclusive. Systematic comparative studies are lacking.
Combination therapies: Whether TENS acts synergistically with physiotherapy, medication or other modalities has been scarcely investigated. RCTs with standardised combination protocols are outstanding.

Frequently Asked Questions

Can TENS be used for fibromyalgia?

Controlled studies show that TENS reduces pain intensity, fatigue and hyperalgesia in fibromyalgia (Proven:). The 2013 study (TENS in fibromyalgia) also demonstrated a restoration of central pain inhibition. However, effects are highly individual, and long-term data are lacking. High-frequency stimulation (80–100 Hz) with segmental electrode placement over painful areas is recommended. Application should be regular (several times daily), as effects are short-lived.

What remains to be clarified is whether sustained benefits can be achieved with prolonged or repeated stimulation protocols.

Why does TENS not work for some patients?

Responsiveness to TENS depends on several factors: pain mechanism (nociceptive vs. neuropathic), stimulation parameters (frequency, intensity) and electrode placement. In central pain syndromes (e.g. post-stroke) or degenerative neuropathies, efficacy is often lower. Patient expectation also plays a role — placebo effects are particularly pronounced with TENS. Individual parameter adjustment and combination with other therapies (e.g. physiotherapy) may enhance effectiveness.

Further research is needed to identify biomarkers predicting TENS responsiveness.

Is TENS suitable for self-application by patients?

TENS devices are approved for self-application and are frequently used in home-based pain therapy. However, correct application (electrode placement, intensity setting) requires instruction by healthcare professionals. Studies show that incorrect parameters (e.g. insufficient intensity) can significantly reduce efficacy. Patients with pacemakers, epilepsy or pregnancy should use TENS only after medical consultation. Compliance is high when patients perceive subjective pain relief.

Future studies should compare self-administered TENS with professionally supervised protocols to assess long-term safety and effectiveness.

Sources

1
Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain
Bjordal JM, Johnson MI, Ljunggreen AE · 2003
2
Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia
Dailey DL, Rakel BA, Vance CGT, Liebano RE, Amrit AS, Bush HM et al. · 2013
3
Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study)
Johnson MI, Paley CA, Jones G, Mulvey MR, Wittkopf PG · 2022
4
Effects of transcutaneous electrical nerve stimulation on pain, pain sensitivity, and function in people with knee osteoarthritis: a randomized controlled trial
Vance CG, Rakel BA, Blodgett NP, DeSantana JM, Amendola A, Zimmerman MB et al. · 2012
5
Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews
Gibson W, Wand BM, Meads C, Catley MJ, O'Connell NE · 2019
6
Transcutaneous Electrical Nerve Stimulation Reduces Movement-Evoked Pain and Fatigue: A Randomized, Controlled Trial
Dailey DL, Vance CGT, Rakel BA, Zimmerman MB, Embree J, Merriwether EN et al. · 2020
7
Transcutaneous electrical nerve stimulation for the control of pain during rehabilitation after total knee arthroplasty: A randomized, blinded, placebo-controlled trial
Rakel BA, Zimmerman BM, Geasland K, Embree J, Clark CR, Noiseux NO et al. · 2014
8
Effects of transcutaneous electrical nerve stimulation (TENS) on acute postoperative pain intensity and mobility after hip fracture: A double-blinded, randomized trial
Elboim-Gabyzon M, Andrawus Najjar S, Shtarker H · 2019
9
Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function and medication
Fiorelli A, Morgillo F, Milione R, Pace MC, Passavanti MB, Laperuta P et al. · 2012
10
Prospective, Randomized, Placebo-controlled Study of the Effect of TENS on postthoracotomy pain and pulmonary function
Erdogan M, Erdogan A, Erbil N, Karakaya HK, Demircan A · 2005
11
High and low frequency TENS reduce postoperative pain intensity after laparoscopic tubal ligation: a randomized controlled trial
Desantana JM, Sluka KA, Lauretti GR · 2009
12
Hypoalgesic effect of the transcutaneous electrical nerve stimulation following inguinal herniorrhaphy: a randomized, controlled trial
DeSantana JM, Santana-Filho VJ, Guerra DR, Sluka KA, Gurgel RQ, da Silva WM · 2008
13
Is transcutaneous electrical nerve stimulation effective in relieving postoperative pain after thoracotomy?
Freynet A, Falcoz PE · 2010
14
Randomised, controlled study of preoperative electroacupuncture for postoperative pain control after cardiac surgery
Coura LE, Manoel CH, Poffo R, Bedin A, Westphal GA · 2011
15
Transcutaneous electrical nerve stimulation after major amputation
Finsen V, Persen L, Løvlien M, Veslegaard EK, Simensen M, Gåsvann AK et al. · 1988
16
The effect of location of transcutaneous electrical nerve stimulation on postoperative opioid analgesic requirement: acupoint versus nonacupoint stimulation
Chen L, Tang J, White PF, Sloninsky A, Wender RH, Naruse R et al. · 1998
17
Transcutaneous electrical nerve stimulation for the control of pain in musculoskeletal disorders
Robinson AJ · 1996

Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.